Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantum Computing Calculations of Protein-Ligand Binding Energies Using Decomposition Methods on Simulated and Real Quantum Hardware.

Journal of chemical information and modeling·2026
Same author

Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

Immunological medicine·2026
Same author

2024 Update of the Asia-Pacific League of Associations for Rheumatology (APLAR) Recommendations for Rheumatoid Arthritis Management.

International journal of rheumatic diseases·2026
Same author

Correction: Diagnostic and therapeutic challenges in concomitant axial spondyloarthritis and rheumatoid arthritis: a case-based review.

Rheumatology international·2026
Same author

Identification of a shared antigen linking CD4<sup>+</sup> T and B cell pathology in Sjögren's disease.

Science advances·2026
Same author

Real-World Implementation of Treatment Intensification After Methotrexate in Rheumatoid Arthritis in the Context of Treat-to-Target Recommendations: Insights From Japan's Claims Data.

Modern rheumatology·2026

相关实验视频

Updated: Feb 25, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K

将B细胞分化模型与现实世界的数据集成,为系统性硬化症中抗体分泌细胞枯竭的决定因素提供了信息.

Tomohisa Nakada1, Ryuta Saito1, Sho Ishigaki2

  • 1Discovery Technology Laboratories, Research Division, Tanabe Pharma Corporation, Yokohama, Japan.

CPT: pharmacometrics & systems pharmacology
|February 23, 2026
PubMed
概括

这项研究模拟了系统性硬化症 (SSc) 中B细胞对CD19和CD20疗法的反应. 高血细胞与血细胞比率预测CD20治疗的反应不佳,与CD19治疗不同.

关键词:
免疫学 免疫学 免疫学基于机制的药理动力学-药理动力学.一个单克隆抗体.个性化医疗是个性化的医疗.基于生理学的药理动力学.量化药理学 量化药理学系统药理学 药理学

更多相关视频

Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
09:25

Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function

Published on: February 16, 2017

12.9K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.2K

相关实验视频

Last Updated: Feb 25, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.8K
Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function
09:25

Detection and Enrichment of Rare Antigen-specific B Cells for Analysis of Phenotype and Function

Published on: February 16, 2017

12.9K
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
10:26

In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells

Published on: January 20, 2019

13.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 计算生物学 计算生物学
  • 类风湿病学 类风湿病学

背景情况:

  • 系统性硬化症 (SSc) 是一种具有高死亡率的自身免疫性疾病,由B细胞驱动.
  • 了解B细胞动态对于开发有效的SSc治疗至关重要.

研究的目的:

  • 开发B细胞分化和SSc.组织分布的系统模型.
  • 描述对CD19+ (伊内比利苏巴) 和CD20+ (瑞图西马布) 细胞枯竭的治疗反应.

主要方法:

  • 将61名未经治疗的SSc患者的现实世界数据 (RWD) 集成到一个系统模型中.
  • 验证了模型并进行了虚拟临床模拟.
  • 分析了B细胞子集的动态,特别是分泌抗体细胞 (ASCs).

主要成果:

  • 虚拟模拟显示CD19细胞动态均,但随着CD20治疗,ASC模式变化.
  • 高血细胞/血细胞 (PC/PB) 比率与CD20治疗反应不佳但CD19消耗稳定相关.
  • 结合CD20的亲和力和消除率影响了Rituximab的治疗变异性.

结论:

  • 系统模型为SSc中对抗CD19和CD20治疗的ASC反应提供了机制性的洞察力.
  • 确定PC/PB比率作为B细胞枯竭疗法治疗疗效的潜在预测指标.
  • 为SSc.提供了一个优化剂量和个性化B细胞枯竭策略的框架.